Athens University teams up with Yale for Covid-19 treatment drug

Researchers from the University of Athens who spearheaded a successful clinical trial into the effects of colchicine in the prevention of complications caused by Covid-19, have teamed up with colleagues at Yale to carry on studying the benefits of the anti-inflammatory drug that was recently approved in Greece and other countries for treating the novel coronavirus.

"The trial, which comprised 105 patients hospitalized with Covid-19, demonstrated that colchicine reduces hospitalization time and the number of intubated patients," the head of the Greek research team, Cardiology Professor Spyridon Defteros, told Kathimerini on Monday.

According to the study, whose findings were published in the prestigious JAMA Network Open journal six months ago, colchicine helps reduce hospitalizations by 25%, the need for respiratory support by 50% and fatalities by 44%.

...